Yahoo! Finance: WPI News

Teva sees revenue more than doubling by 2015 (Reuters)

Thu, 7 Jan 2010 22:13:04 Etc/GMT

Teva Pharmaceutical Industries Ltd , the world's largest generic drugmaker, on Thursday set a target of revenue of $31 billion in 2015, more than double its current annual amount as it sees major growth in overall use of generics.

UPDATE - Teva sees revenue more than doubling by 2015 (at Reuters)

Thu, 7 Jan 2010 22:00:51 Etc/GMT

Cephalon's Nuvigil Under Pressure (Zacks.com)

Thu, 7 Jan 2010 15:37:32 Etc/GMT

Watson Pharmaceuticals seeking OK to sell generic version of Cephalon’s Nuvigil (at bizjournals.com)

Wed, 6 Jan 2010 19:05:24 Etc/GMT

Cephalon sues Watson over sleep drug Nuvigil (AP)

Wed, 6 Jan 2010 17:15:35 Etc/GMT

Cephalon Inc. on Wednesday confirmed it is suing generic drug developer Watson Pharmaceuticals Inc. over that company's plan to make a generic version of Cephalon's sleep disorder drug Nuvigil.

Watson Files FDA Application for Generic Nuvigil(R) (PR Newswire)

Wed, 6 Jan 2010 16:06:00 Etc/GMT

Watson Pharmaceuticals, Inc. , a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., a Nevada Corporation, filed an Abbreviated New Drug Application with the U.S.

Cephalon sues Watson Pharma for drug patent infringement (at Reuters)

Wed, 6 Jan 2010 14:41:28 Etc/GMT

Watson to Present at 28th Annual JPMorgan Healthcare Conference (PR Newswire)

Wed, 6 Jan 2010 13:00:00 Etc/GMT

Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the 28th Annual JPMorgan Healthcare Conference on Wednesday, January 13, 2010 at 12:00 pm Eastern Standard Time, at the Westin St.

Watson Pharmaceuticals: Look-Ahead to December 2009 Quarterly Results (at Seeking Alpha)

Tue, 29 Dec 2009 09:18:33 Etc/GMT

4-Star Stocks on the Upswing (at Motley Fool)

Tue, 22 Dec 2009 19:33:06 Etc/GMT

UPDATE - Ratiopharm to beat own expectations for 2009 (at Reuters)

Tue, 22 Dec 2009 08:47:50 Etc/GMT

According To Credit Suisse Vice President, Certain Health Care Stocks To Benefit Greatly From U.S. Legislation: Which Companies Stand To Benefit The Most? (Wall Street Transcript)

Mon, 21 Dec 2009 22:40:00 Etc/GMT

67 WALL STREET, New York - December 21, 2009 - The Wall Street Transcript has just published its Consumer Health Services Report offering a timely review of the sector to serious investors and industry executives. This 53 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

[$$] A Look at the Market Leaders (at RealMoney by TheStreet.com)

Mon, 14 Dec 2009 18:15:23 Etc/GMT

Large And Small Cap Picks In The Health Care Space: Credit Suisse Analyst Guides Investors On Which Stocks Are A Good Buy (Wall Street Transcript)

Mon, 14 Dec 2009 16:55:00 Etc/GMT

67 WALL STREET, New York - December 14, 2009 - The Wall Street Transcript has just published its Consumer Health Services Report offering a timely review of the sector to serious investors and industry executives. This 53 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

Stealth Generic Drug Play: 1 Minute Trade (TheStreet.com TV)

Mon, 14 Dec 2009 14:04:36 Etc/GMT

http://us.news2.yimg.com/us.yimg.com/p/fi/26/39/43.jpg/yfinance/tscm/strategysession/10643905http://www.thestreet.com/

Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy (PR Newswire)

Mon, 14 Dec 2009 13:50:00 Etc/GMT

Watson Pharmaceuticals, Inc. today announced a new program encouraging health professionals to help maintain the bone health of prostate cancer patients who are on long-term androgen deprivation therapy . Nearly two million men are receiving ADT, a palliative treatment for prostate cancer that, while highly effective and considered the "gold therapy," can cause bone loss and increase a man's risk for osteoporosis.

How to Play Generic Drug Stocks (at Minyanville.com)

Mon, 14 Dec 2009 12:40:00 Etc/GMT

As the patent cliff nears, copycats are gearing up.

[video] Stealth Generic Drug Play: 1 Minute Trade (at TheStreet.com)

Fri, 11 Dec 2009 14:38:24 Etc/GMT

Coverage initiated on Watson Pharm by Piper Jaffray (Briefing.com)

Fri, 11 Dec 2009 13:18:37 Etc/GMT

Equity Valuations In The Health Care Service Space Not To Be Affected By Unemployment Levels, According To BMO Analyst (Wall Street Transcript)

Thu, 10 Dec 2009 20:14:00 Etc/GMT